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Abstract
During human and murine cytomegalovirus (MCMV) infection an exceptionally large virus-specific CD8 T cell pool is
maintained in the periphery lifelong. This anomalous response is only seen for specific subsets of MCMV-specific CD8 T cells
which are referred to as ’inflationary T cells’. How memory CD8 T cell inflation is induced and maintained is unclear, though
their activated phenotype strongly suggests an involvement of persistent antigen encounter during MCMV latency. To
dissect the cellular and molecular requirements for memory CD8 T cell inflation, we have generated a transgenic mouse
expressing an MHC class I-restricted T cell receptor specific for an immunodominant inflationary epitope of MCMV. Through
a series of adoptive transfer experiments we found that memory inflation was completely dependent on antigen
presentation by non-hematopoietic cells, which are also the predominant site of MCMV latency. In particular, non-
hematopoietic cells selectively induced robust proliferation of inflationary CD8 T cells in lymph nodes, where a majority of
the inflationary CD8 T cells exhibit a central-memory phenotype, but not in peripheral tissues, where terminally
differentiated inflationary T cells accumulate. These results indicate that continuous restimulation of central memory CD8 T
cells in the lymph nodes by infected non-hematopoietic cells ensures the maintenance of a functional effector CD8 T pool in
the periphery, providing protection against viral reactivation events.
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Introduction
Memory CD8 T cells develop following primary encounter with
an infectious agent and provide protection against subsequent
infections. Depending on their phenotype and anatomical
location, memory CD8 T cells have been categorized into central
memory CD8 T cells (TCM) and effector-memory CD8 T cells
(TEM) [1,2]. TCM localize to secondary lymphoid organs due to
expression of the lymph nodes homing markers CD62L and
CCR7, and are maintained by homeostatic proliferation respond-
ing to the cytokines IL-7 and IL-15 [3,4]. Because of their self-
renewal properties and their exquisite ability to proliferate and
exert effector function upon re-encounter with the original
pathogen, TCM are able to provide long-term protective immunity.
TEM, in contrast, reside predominantly in the periphery, usually at
the site of primary infection, and possess a terminally differentiated
phenotype, characterized by low expression of IL7Ra and CD62L
and high expression of killer cell lectin-like receptor G1 (KLRG1).
TEM are believed to form the front line of defense against re-
infections due to their immediate activation upon secondary
infection at peripheral sites and due to their ready performance of
effector functions [5,6]. In absence of antigen, their long-term
maintenance in the periphery is generally believed to be unstable.
However, this notion has recently been challenged by the
demonstration of long-term maintenance of effector memory cells
in the skin, gut and brain in absence of detectable antigen
persistence [7,8,9]. Studying the development and function of
memory CD8 T cells should always take into account the nature of
the infectious agent, as the duration of the initial antigen
stimulation, the level of inflammation, the persistence of the
pathogen, the cell tropism as well as the ability to interfere with the
antigen presentation machinery of the host, are all factors
influencing the development of the memory CD8 T cell response
[10,11,12]. In particular, generation of memory responses are
known to be highly perturbed during chronic or latent viral
infections, where persistent antigen stimulation has often been
shown to lead to functional impairment and antigen-dependent
maintenance of CD8 T cells [13,14,15].
Infection with the b-herpes virus cytomegalovirus (CMV) leads
to disseminated acute lytic replication which is controlled by
various immune effector cells [16,17,18,19], followed by life-long
latency with presumably sporadic and low-level viral reactivation
events [20,21]. Thus, CMV infection allows studying memory
CD8 T cell responses in the context of a latent/persistent viral
infection. Both humans and mice are natural hosts of CMV and
both elicit an impressively large virus-specific memory CD8 T cell
response during latency which increases with time, a phenomenon
referred to as ‘memory inflation’ [22,23,24,25,26]. Longitudinal
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analysis performed in mice revealed that upon infection with
MCMV, two major kinetic patterns of CD8 T cell responses
emerge: the majority of CD8 T cells, referred to as ‘conventional
CD8 T cells’, undergo expansion during the acute phase of
infection followed by rapid contraction, eventually resulting in low
numbers of TCM cells which are stably maintained during latency
by homeostatic proliferation. In contrast, so called ‘inflationary
CD8 T cells’, continue to expand even after control of acute
infection, and are maintained at high percentages in the absence of
overt viral replication [27,28]. However, these cells display a TEM
phenotype, strongly suggesting that their accumulation and
maintenance is driven by viral antigen [27,28,29]. Therefore, it
has been postulated that during MCMV latency, low levels of viral
gene expression/antigen presentation in latently infected cells,
undergoing viral reactivation, would constantly stimulate infla-
tionary CD8 T cells, which in turn would prematurely terminate
such viral reactivation attempts [21,30]. However, Snyder et al.
showed that inflationary CD8 T cells divide only sporadically
during latency and that they are not maintained in an antigen-
dependent manner, thereby favoring a model where the
inflationary pool is maintained by continuous replacement of
newly activated effector CD8 T cells [29].
However, critical aspects regarding the mechanism of antigen
presentation during MCMV latency are still unknown. We
recently showed that contrary to the primary expansion during
the acute phase of infection, which was largely driven by cross-
presenting dendritic cells (DCs), accumulation and maintenance of
the inflationary CD8 T cell pool occurred in absence of cross-
presenting DCs, arguing for different antigen presentation
requirements during memory inflation [31]. In addition, priming
and inflation also differ in their costimulatory requirements, the
latter being independent of B7-CD28 interaction [32]. Taking
together, these data suggest that antigen presentation during
latency might not depend on DCs, but on other cell types which
are presumably hosting latent viral genomes and directly
presenting viral antigens to the inflationary CD8 T cells.
A major obstacle in studying memory inflation is the lack of a
monoclonal population of inflationary CD8 T cells that can be
tracked in vivo during the entire course of MCMV infection.
Therefore, we generated MHC class I-restricted TCR transgenic
mouse lines with specificity for the MCMV-derived epitope M38,
representing an immunodominant epitope of the inflationary
response in C57BL/6 mice. Through a series of adoptive transfer
experiments, we discovered that memory inflation was completely
dependent on antigen presentation by non-hematopoietic cells.
Consistent with this, we identified non-hematopoietic cells as
major carriers of MCMV genomes during the whole course of the
infection, especially during latency. While inflationary CD8 T cells
with an effector phenotype accumulated during latency in the
periphery without increased local proliferation, a small proportion
of inflationary CD8 T cells in lymph nodes, displaying a TCM
phenotype, proliferated extensively during latency. We propose a
mechanism where latently infected non-hematopoietic cells
stochastically present viral antigens to TCM CD8 T cells in lymph
nodes, which differentiate into effector cells and migrate to
peripheral tissues where they do not further proliferate but instead
facilitate the control of local viral reactivation events.
Results
Tissue-specific pattern of MCMV-specific CD8 T cell
responses
Infection of C57BL/6 mice with MCMV results in viral
replication which is controlled by the immune system with an
organ-dependent kinetics: clearance of infectious virus was first
observed in the spleen and in the lymph nodes, followed by the
lungs, liver and lastly salivary glands, where lytic replication
persisted for at least two months (Fig. 1A and B). By day 150 post
infection infectious virus was no longer detected in any organ,
despite the presence of latent viral genomes [33]. MCMV
infection induces two distinct patterns of CD8 T cell responses:
a conventional and an inflationary response. Conventional CD8 T
cells, which are dominated by M45-specific CD8 T cells, contract
after the resolution of the acute phase of infection to eventually
generate low numbers of TCM CD8 T cells (Fig. 1C). Inflationary
CD8 T cells, exemplified by M38-specific CD8 T cells,
accumulate until a stable plateau is reached. These two kinetic
patterns were observed in the spleen and in peripheral organs such
as lungs and liver (Fig. 1 C, liver not shown), where M45-specific
CD8 T cells contracted between day 7 and day 14 post infection
while M38-specific CD8 T cells increased until day 14–28 post
infection to eventually stabilize at high percentages. In these
organs, the majority of M45-specific CD8 T cells were
IL7RahighKLRG1low and expressed high levels of CD62L (not
shown) by day 150 after infection (Fig. 1D, bottom panels),
reminiscent of a TCM phenotype. In contrast, M38-specific CD8 T
cells displayed largely an effector phenotype (IL7RlowKLR-
G1highCD62Llow), especially in the lungs (Fig 1 D, top panels)
and in the liver (not shown). Interestingly, in the lymph nodes (here
the inguinal LN is shown) M38-specific CD8 T cells did not inflate
and were present at much lower percentages than in spleen and
peripheral tissues (Fig. 1C). Moreover, about 50% of M38-specific
CD8 T cells displayed a TCM phenotype, independent of the
anatomical location of the LNs analyzed (Fig. 1D and Fig. S1).
Thus, during MCMV infection two different CD8 T cell
response patterns were induced, whose kinetics and phenotype
were strongly influenced by their anatomical location. Strikingly,
M38-specific CD8 T cells exhibited a pronounced TEM phenotype
in peripheral tissues and spleen whereas a predominant TCM
phenotype was observed in lymph nodes.
Author Summary
Cytomegaloviruses (CMVs) infect the majority of the
human population and persist lifelong via latency. CMV
latency is thought to be a dynamic state, characterized by
stochastic viral reactivation events coupled to CMV-
derived antigen presentation. In support of this hypothesis
is the exceptionally large CMV-specific CD8 T cell response
which constitutes an integral part of immune surveillance
of CMV reactivation. Conversely, it may also contribute to
immune senescence as it significantly shapes the overall
CD8 T cell pool in bias of CMV-specificity. In mice, only a
subset of CMV-specific CD8 T cells, also called ‘inflationary
CD8 T cells’, contribute to this large response. The
mechanism leading to the selective accumulation and
persistence of memory CD8 T cells during MCMV latency is
largely unknown. Here, we unraveled the mechanisms of
memory CD8 T cell inflation using a newly generated TCR
transgenic mouse with specificity for an immunodominant
inflationary MCMV epitope. We show that antigen
presentation on non-hematopoietic cells is essential for
memory inflation and that memory inflation in peripheral
tissues is fueled by lymph node-resident central memory
CD8 T cells, being locally reactivated by non-hematopoi-
etic cells, inducing their local expansion and migration to
peripheral tissues where they control viral reactivation
events.
Mechanism of CD8 T Cell Inflation in CMV Infection
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Generation of MHC class I-restricted TCR transgenic mice
with specificity for the M38 epitope of MCMV
To dissect the cellular and molecular requirements for memory
inflation, adoptive transfer experiments of MCMV-specific CD8 T
cell populations at various differentiation statuses and at various
time points of infection are required, optimally using monoclonal
T cell populations to normalize the heterogeneity inherent within
total populations. Therefore, we generated TCR transgenic mouse
lines with specificity for the MCMV-derived M38 epitope.
For this, we first generated T cell hybridomas specific for the
M38-derived epitope and focused on one high affinity hybridoma
who’s TCR variable regions were identified as Va4Ja13 and
Vb10Jb2.1 (nomenclature according to Wilson et al., [34]). The
rearranged genomic variable regions were amplified and cloned
into TCR cosmid expression vectors which have been previously
shown to allow efficient expression of transgenic TCRs [35]. Co-
injection of the linearized transgenes into fertilized C57BL/6
oocytes gave rise to two different mouse lines, which we called
Mini and Maxi (Fig. 2A). The Mini mouse was transgenic for the
Vb10Jb2.1 chain only, which was expressed by nearly 100% of the
CD8 T cells, while the TCRa chain was of endogenous origin (not
shown). This increased the percentage of naı¨ve M38-specific CD8
T cells from undetectable levels in C57BL/6 mice to ,10%. The
Maxi mouse was transgenic for both Va4Ja13 and Vb10Jb2.1
variable regions, resulting in a percentage of M38-specific CD8 T
cells among total naı¨ve CD8 T cells of around 90% (Fig. 2A).
To compare the relative affinities of the TCRs expressed by the
Mini and Maxi CD8 T cells, we first analyzed their dose response
to graded amounts of M38 peptide in vitro. Both Mini and Maxi
CD8 T cells were specific for the M38 peptide, though Maxi CD8
T cells had a 109000-fold higher affinity compared to Mini CD8 T
cells as identified by in vitro proliferation (Fig. 2B). To determine
the ability of transgenic CD8 T cells to proliferate in vivo in
response to MCMV infection, we adoptively transferred 105 Mini
or 104 Maxi CD8 T cells into C57BL/6 mice one day prior to
infection and compared endogenous and transgenic M38-specific
CD8 T cell responses in the blood at different time points after
infection (Fig. 2C). Adoptively transferred cells were distinguished
from endogenous cells by expression of the CD45.1 congenic
marker. Mini CD8 T cells responded to MCMV infection
comparable to the endogenous M38-specific CD8 T cells over
the whole course of the infection, showing inflation and
maintenance at high percentages during latency with a TEM
phenotype (Fig. S2). The much higher affinity of the TCR
expressed by Maxi CD8 T cells resulted in a 10-fold higher
expansion during the acute phase of infection compared to
equivalent starting numbers of transferred Mini CD8 T cells.
Interestingly, the classical inflationary behavior was not observed
for the Maxi CD8 T cells, as a contraction phase followed the
expansion phase. Nevertheless, Maxi CD8 T cells were still
maintained at high percentages during latency and displayed a
TEM phenotype, indicative of the inflationary response (Fig. S2).
Thus, the Maxi mouse is a source of a monoclonal population of
CD8 T cells that expresses a TCR with an exquisitely high affinity
for the M38-derived antigen. In contrast, CD8 T cells that
originate in the Mini mouse are highly enriched in M38-specific
CD8 T cells and are rather polyclonal, which renders them well
suited for adoptive transfer experiments mimicking the endoge-
nous response that is induced in vivo upon MCMV infection.
Antigen presentation by non-hematopoietic cells is
essential for M38-specific CD8 T cell inflation
With the assumption that memory inflation is dependent on
MHC class I-antigen complex recognition and with the availability
Figure 1. Tissue-specific pattern of MCMV-specific CD8 T cell responses. (A) C57BL/6 mice were infected with MCMV-Dm157 and virus titers
were determined in the spleen, lungs, liver and salivary glands (SG) at days 7, 14, 28 and 150. In a separate experiment, virus titers were determined in
the axillary lymph nodes at days 4, 6 and 12 post infection (B). The horizontal lines represent the respective detection limits. (C) The percentage of
M38- (black bars) and M45-specific CD8 T cells (white bars) were measured by tetramer staining in the spleen, lungs and inguinal lymph nodes at the
indicated time points post MCMV infection. For spleen and lungs, bars show averages of three mice per group 6 SEM, whereas for lymph nodes bars
represent cells pooled from three mice. (D) Representative plots showing KLRG-1 and IL7Ra expression on M38- and M45-specific CD8 T cells in the
spleen, lungs and inguinal lymph nodes on day 150 post infection. All data are representative of at least three independent experiments.
doi:10.1371/journal.ppat.1002313.g001
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of the TCR transgenic CD8 T cells, we sought to determine which
cell types are responsible for antigen presentation to inflationary
CD8 T cells. In particular, we addressed the question whether H-
2Kb restricted M38-specific CD8 T cells require antigen presen-
tation by hematopoietic or non-hematopoietic cells for their
inflation. To this end, we generated bone marrow chimeras in
which the MHC class I H-2Kb molecule was expressed on every
cell type (WTRWT) or selectively removed on non-hematopoietic
cells (WTRH-2Kb2/2), and compared these two groups of mice
for their kinetics of M38- and M45-specific (H-2Db-restricted)
CD8 T cell responses. To overcome the absence of positive
selection of H-2Kb restricted CD8 T cells in H-2Kb2/2 recipient
mice, we adoptively transferred congenically marked Mini CD8 T
cells the day prior to infection. We first compared the kinetics of
M38- and M45-specific CD8 T cell responses in the blood
(Fig. 3A). As expected, in WTRWT mice M45-specific CD8 T
cells underwent the classical expansion-contraction kinetics typical
of a conventional response, while M38-specific CD8 T cells
expanded until day 15 post infection, after which they stabilized at
high percentages (Fig. 3A, left graph). Strikingly, memory inflation
was not at all induced in WTRH-2Kb2/2 mice (Fig. 3A, right
graph) in the absence of antigen presentation by non-hematopoi-
etic cells. Instead, M38-specific CD8 T cells underwent classical
expansion and contraction kinetics as observed for M45-specific
CD8 T cells.
Next, we investigated whether antigen presentation by non-
hematopoietic cells was also a prerequisite for memory inflation in
peripheral tissues. Consistent with the blood data, we measured a
20-fold reduction of M38-specific CD8 T cells in WTRH-2Kb2/2
compared to WTRWT mice (Fig. 3B and C) in the lungs of latently
infected mice. Similar results were obtained in the spleen and in the
liver (not shown). A hallmark of inflationary CD8 T cells is their
activated phenotype, which has been suggested to be a consequence
of presentation of viral-derived antigens during latency. If this is
true, then absence of antigen sensing on non-hematopoietic cells
would favor the formation of TCM M38-specific CD8 T cells during
latency. This was indeed the case: in both the spleen and the lungs of
latently infected WTR H-2Kb2/2 mice, M38-specific CD8 T cells
up-regulated the expression of IL7Ra and CD62L to a similar
extent as in M45-specific CD8 T cells. M38-specific CD8 T cells
also displayed high expression of CD122 in WTRH-2Kb2/2 mice,
allowing for IL-15-mediated homeostatic proliferation (not shown).
Importantly, this was the case despite comparable abundance of
viral genomes in the spleen and lungs of WTRWT and WTRH-
2Kb2/2 mice on day 60 post infection (Fig. 3E), indicating that
latency was established in WTRH-2Kb2/2 mice and that absence
of memory inflation was due to impaired/missing antigen
presentation. Moreover, virus titers were comparable on day 7
post infection, and by day 60 post infection virus control was almost
complete in every organ analyzed in both WTRWT and WTRH-
2Kb2/2 chimeras (Fig. 3F).
These data show that antigen presentation by non-hematopoi-
etic cells is a prerequisite for memory inflation during MCMV
infection. In its absence, inflationary CD8 T cells are undistin-
guishable from the conventional CD8 T cells with respect to their
kinetics and phenotypes.
Restriction of antigen presentation to DCs abrogates
memory inflation
Memory inflation is not solely restricted to CD8 T cells specific
for the M38-derived antigen. In C57BL/6 mice, at least three
other MCMV-derived antigens have been identified that induce
CD8 T cell inflation, namely IE3416–425, IE3461–475, and m139. To
investigate whether antigen presentation by non-hematopoietic
Figure 2. Generation of MHC class I-restricted TCR transgenic
mice with specificity for the M38 epitope of MCMV. (A)
Splenocytes from WT C57BL/6 mice and from the transgenic mouse
lines Mini and Maxi were stained with M38-tetramer (top panels) and
with anti-Vb10 antibody (lower panels). Percentages of CD8+ M38+ and
CD8+ Vb10+ are depicted in the plots and are representative of at least
10 individual mice. (B) 66105 Mini CD8 T cells and 66104 Maxi CD8 T
cells were CFSE labeled and incubated with DCs loaded with the
indicated concentration of M38 peptide or with medium for three days.
The percentages of CFSElow cells are depicted. Bars show averages of
three mice per group6 SEM, and one of two independent experiments
is shown as representative. (C) 105 Mini CD8 T cells or 104 Maxi CD8 T
cells expressing the CD45.1 congenic marker were adoptively
transferred into CD45.2 recipient C57BL/6 mice one day prior to
infection with MCMV. The percentages of endogenous (black circles)
and transferred (white circles) M38-specific CD8 T cells were measured
by tetramer staining from blood samples collected at the indicated time
points after infection. Each point shows the average of three to five
mice per group 6 SEM. One of at least five (for Mini CD8 T cells) and
two (for Maxi CD8 T cells) independent experiments are shown as
representative.
doi:10.1371/journal.ppat.1002313.g002
Mechanism of CD8 T Cell Inflation in CMV Infection
PLoS Pathogens | www.plospathogens.org 4 October 2011 | Volume 7 | Issue 10 | e1002313
cells is a general requirement for memory inflation, we took
advantage of Tg(CD11c-b2m)6Tg(K14-b2m)6b2m
2/2 mice (DC-
MHCI) [36,37]. These mice are b2-microglobulin
2/2 mice with a
tissue specific expression of transgenic b2-microglobulin in
dendritic cells (DCs), on keratinocytes and on the thymic cortical
epithelium, ensuring positive selection of CD8 T cells in the
thymus. As a result, only DCs (and keratinocytes) are able to
present antigens in secondary lymphoid organs and peripheral
tissues in the context of MHC class I molecules in DC-MHCI
mice. The presence of a normal peripheral CD8 T cell
compartment in these mice [36] allows the assessment of
endogenous H-2Kb and H-2Db-restricted CD8 T cell responses.
Similarly as described above, WT and DC-MHCI mice were
lethally irradiated and reconstituted with bone-marrow derived
from WT mice (WTRWT and WTR DC-MHCI) or from DC-
MHCI mice (DC-MHCI RWT and DC-MHCI R DC-MHCI).
We first analyzed the M38-specific CD8 T cell response in the
blood, which confirmed the previous results and verified the
validity of this model (Fig. 4A). In fact, memory inflation was only
induced in the two groups of mice where the recipients were WT,
irrespective of the origin of the hematopoietic cells, but not in DC-
MHCI recipient mice. Notably, when DCs were the only cell type
capable of presenting viral antigens (DC-MHCI R DC-MHCI),
this had no effect on the expansion of M45-specific CD8 T cells
during acute infection and showed only a minor reduction for
M38-specific CD8 T cells (Fig. S3), implying that DCs alone are
sufficient for priming and expansion of MCMV-specific CD8 T
cell responses, but not for their inflation. To investigate the
Figure 3. Antigen presentation by non-hematopoietic cells is essential for M38-specific CD8 T cell inflation. WTRWT and WTR
H-2Kb2/2 chimeric mice were generated by irradiating WT and H-2Kb2/2 mice followed by reconstitution with WT bone-marrow. One day prior infection
with MCMV-Dm157, 105 CD45.1+ Mini CD8 T cells were adoptively transferred. (A) The percentage of M38- (pregated on CD45.1+ cells) and M45-specific
CD8 T cells among total CD8 T cells were measured in the blood on days 7, 12, 15, 28 and 65 post infection. Every point represents the average of four
individual mice 6 SEM. The mice shown in (A) were sacrificed on day 100 post infection and the percentage of M38- (pregated on CD45.1+ cells) and
M45-specific CD8 T cells among total CD8 T cells (B) and their total numbers (C) were determined in the lungs. Bars indicate averages of four mice per
group6 SEM. The relative expression of IL7Ra and CD62L on M38- and M45- specific CD8 T cells is indicated in (D) in the same groups of mice shown in
(A) for lungs and spleen. (E) MCMV latent genomes were quantified in the spleen (upper panel) and in the lungs (lower panel) of WTRWT (black circles)
and WTRH-2Kb2/2 mice (white circles) on day 60 post infection or from naı¨ve mice by qPCRs using primers specific for b-actin and the MCMV-encoded
M38 gene. The relative amount of viral genome was calculated using the delta-delta Ct method, where 1026 was the highest value detected for naı¨ve
mice and used as detection limit. Data pooled from two independent experiments are shown. (F) Virus titers were determined in spleen, lungs, liver and
salivary glands on day 7 (top panel) and day 60 (bottom panel) in WTRWT (black circles) and WTRH-2Kb2/2 (white circles) mice. Lines represent the
geometric means of three individual mice. One of at least four independent experiments are shown for (A to D) and of two independent experiments for
(E to F). Significances were analyzed by Student’s t test. *, P,0.05; **, P,0.01; *** P,0.001; ****, P,0.0001.
doi:10.1371/journal.ppat.1002313.g003
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consequences of selective depletion of antigen presentation by
non-hematopoietic cells for inflation of CD8 T cells specific for
other antigens, we measured the responses to M38 and to
IE3416–425 in the lungs of mice which had been infected for 120
days (Fig. 4B). We found a similar pattern of responses for the two
inflators, namely a 5–10-fold reduction in DC-MHCI compared to
WT recipient mice, suggesting that inflation of IE3-specific CD8 T
cells was also dependent on antigen presentation by non-
hematopoietic cells. Consistent with the data shown above,
absence of antigen-presentation by non-hematopoietic cells
resulted in up-regulation of IL-7Ra on M38- and IE3-specific
CD8 T cells during latency (not shown). Thus, DCs are sufficient
for priming of both the conventional and inflationary response,
whereas inflation requires antigen presentation by cells of non-
hematopoietic origin.
Non-hematopoietic cells promote extensive and
systemic cell proliferation in the early phase of MCMV
infection, but only in lymph nodes during latency
By careful kinetic analysis, the inflationary M38-specific CD8 T
cell response can be divided into three consecutive phases: the
primary expansion between day 0 and 9 post infection (Fig. 5A,
yellow area), a first and most pronounced inflation (secondary
expansion) from day 11 and day 15 post infection (Fig. 5A, pink
area) followed by a maintenance phase (Fig, 5A, blue area)
(Fig. 5A). In contrast, in WTRH-2Kb2/2 mice primary
expansion was followed by contraction instead of secondary
expansion, suggesting that antigen presentation by non-hemato-
poietic cells promotes either survival of the effector cells or/and
prolongs cell proliferation. To distinguish between these two
possibilities, we first analyzed the expression profiles of the anti-
apoptotic molecule Bcl-2 in adoptively transferred Mini CD8 T
cells in WTRWT and WTRH-2Kb2/2 mice over the course of
MCMV infection. At the peak of primary expansion, Mini CD8 T
cells down-regulated Bcl-2 expression in both groups of mice,
consistent with their highly activated phenotype (Fig. 5B, yellow
area). However, contraction of Mini CD8 T cells in WTRH-
2Kb2/2 mice resulted in a continuous up-regulation of Bcl-2,
comparable to conventional M45-specific CD8 T cells, whereas
Mini CD8 T cells remained Bcl-2low in WTRWT mice during
secondary expansion (Fig. 5B, pink area and Fig. S4). These data
are in line with the notion that absence of antigen presentation by
non-hematopoietic cells abrogates inflation and results in gener-
ation of long-lived M38-specific TCM CD8 T cells during latency.
Unexpectedly, even in WTRWT mice where contraction never
happens, Mini CD8 T cells started to up-regulate the expression of
Bcl-2 at the onset of the maintenance phase, despite their
phenotype remaining activated (Fig. 5B, blue area). Likewise, we
observed a constant up-regulation of Bcl-2 expression by the
endogenous M38-specific CD8 T cells (and as expected by M45-
specific CD8 T cells) in the lungs (Fig. S4). From these data we
exclude that non-hematopoietic cells provide surviving stimuli to
inflationary CD8 T cells at the peak of the primary expansion
preventing their contraction, instead they might deliver additional
antigen stimulation resulting in prolonged cell activation and
proliferation. This was confirmed by the expression profile of the
proliferative marker Ki67 which was concomitantly analyzed with
Bcl-2 expression. Indeed, Mini CD8 T cells underwent a second
round of proliferation in WTRWT mice exactly at the time when
secondary expansion was induced (Fig. 5C, pink area), but not in
WTRH-2Kb2/2 mice, where Ki67+ Mini cells sharply decreased
during the contraction phase and remained low for the rest of the
infection. Consistent with the results by Snyder et al. who showed
that inflationary CD8 T cells were dividing only sporadically
during latency [29], we observed a decrease of proliferating Mini
CD8 T cells at the onset of the maintenance phase in WTRWT
mice (Fig. 5C, blue area) to eventually reach the low level of
proliferation measured in WTRH-2Kb2/2 as latency was
established (D60: WTRWT: 7%; WTRH-2Kb2/2: 3%).
Next, we analyzed whether the proliferation pattern observed in
the blood was also apparent in lymphoid and peripheral tissues.
We therefore analyzed Ki67/Bcl-2 expression in M38-specific and
M45-specific CD8 T cells isolated from lungs or lymph nodes on
day 12 post infection and during latency (Fig. 5D, E and F).
Analogous to the blood, M38-specific CD8 T cells in WTRWT
mice showed increased proliferation compared to WTRH-2Kb2/2
mice on day 12 post infection, especially in the lymph nodes
(Fig. 5E). Strikingly, by 4 months post infection (Fig. 5D and F)
M38-specific cell proliferation had ceased almost completely in the
lungs as was the case for M45-specific cells, while it was still ongoing
at high levels in the lymph nodes. Importantly, while the few Ki67+
M45-specific CD8 T cells in the lymph nodes were Bcl-2high,
indicative of cytokine-driven homeostatic proliferation, proliferating
M38-specific CD8 T cells were Bcl-2low, suggesting that their
Figure 4. Restriction of antigen presentation to DCs abrogates memory inflation. WTRWT, DC-MHCIRDC-MHCI, WTRDC-MHCI, DC-
MHCIRWT chimeric mice were generated by reconstituting WT and DC-MHCI irradiated mice with WT and DC-MHCI bone marrow. All groups (3–5
mice per group) were infected with MCMV-Dm157 and the M38-specific CD8 T cell response was measured by tetramer staining from blood samples
obtained on days 7, 9, 13, 20 and 45 post infection (A). The experiment was terminated on day 120 post infection and M38-, IE3-, and M45-specific
CD8 T cell responses were quantified in the lungs by tetramer staining (B). One of two independent experiments is shown. Significances were
analyzed by Student’s t test. *, P,0.05; **, P,0.01; *** P,0.001.
doi:10.1371/journal.ppat.1002313.g004
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Figure 5. Non-hematopoietic cells promote extensive and systemic cell proliferation in the early phase of MCMV infection, but only
local during latency. 105 Mini-CD8 T cells were transferred in WTRWT and WTRH-2Kb2/2 chimeric mice one day prior to infection with MCMV-
Dm157. (A) The percentage of M38-specific CD8 T cell response was measured in the blood on days 7, 9, 11, 13, 17, 21, 27, 42 and 60 post infection.
Colors indicate different phases of the M38-specific response: primary expansion in yellow; secondary expansion in pink; maintenance phase in blue.
Bcl-2 (B) and Ki67 (C) expression levels were measured on M38-specific CD8 T cells depicted in (A). One of two independent experiments is shown. (D)
Representative FACS plots showing Bcl-2 and Ki67 expression on M38- and M45-specific CD8 T cells in the lungs and inguinal lymph nodes of
WTRWT chimeric mice on day 12 post infection (upper panels) and day 130 post infection (lower panels). (E) The percentage of ki67+ cells in
WTRWT and WTRH-2Kb2/2 chimeric mice is shown for M38- and M45-specific CD8 T cells in the lungs (left graph) and in the lymph nodes (right
graph). One of three independent experiments is shown. (F) The percentage of M38-specific cells expressing Ki67 during latency is shown for the
lungs and the lymph nodes. Data pooled from three independent experiments 6 SEM are shown. (G) Preferential antigen-driven proliferation of TCM
M38-specific CD8 T cells during latency. Experimental layout: CD45.2+ C57BL/6 mice were adoptively transferred with CD45.1+ Maxi CD8 T cells and
during latency TCM Maxi CD8 T were isolated from the LNs and the spleen, whereas TEM Maxi CD8 T cells were isolated from the lungs. Isolated cells
were labeled with CFSE and transferred into naı¨ve or latently infected CD45.2+ C57BL/6 mice (Number of transferred cells: TCM = 209000/mouse,
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proliferation was antigen driven. Since M38-specific CD8 T cells
display largely a TCM phenotype in lymph nodes, our data strongly
suggest that central-memory cells in the lymph node, and not
effector memory cells in peripheral tissues, respond to antigen
presentation on non-hematopoietic cells during latency by prolif-
eration. To test this hypothesis, we adoptively transferred in vivo
generated TEM or TCM M38-specific CD8 T cells into latently
infected mice or naı¨ve mice, and assessed their proliferative history
30 days later (Fig. 5G). As expected, TCM M38-specific CD8 T cells
proliferated to a much higher extent compared to TEM M38-specific
CD8 T cells in latently infected recipients (Fig. 5H and I).
Together, these data suggest that antigen presentation by non-
hematopoietic cells promote extensive and systemic proliferation
of M38-specific CD8 T cells during the early phase of the
infection, resulting in their secondary expansion. However,
subsequent maintenance of the peripheral inflationary pool at
high percentage during latency cannot be attributed to extensive
systemic cell proliferation, but instead might be facilitated by
prolonged survival of the inflationary cells, perhaps facilitated by
Bcl-2 upregulation, and by continuous recruitment of newly
activated central memory CD8 T cells from lymph nodes.
MCMV genomes preferentially localize in non-
hematopoietic cells
Given that priming and memory inflation rely on antigen
presentation by different cell types, the first being dependent on
DCs and the latter on non-hematopoietic cells, it is conceivable
that productive infection during the acute phase of infection and
establishment of latency occurred in different cell types. We aimed
to analyze the target cells of MCMV distinguishing between
hematopoietic cells or non-hematopoietic cells in secondary
lymphoid organs and in peripheral tissues at different time points
of the infection. To this end, we isolated spleen and lungs from
WT mice on day 7, 14 and 28 after infection and stained the
isolated cells with anti-CD45 antibody, a known marker for
hematopoietic cells. The proportion of cells that stained positive
for CD45 was roughly,80% in the spleen and,60% in the lungs
(not shown). We then sorted CD45-positive and CD45-negative
cell populations and measured the relative MCMV genome
content by quantitative real time PCR (qPCR). In both the spleen
and the lungs, we found a clear bias towards the CD45-negative
population at every time point analyzed (Fig 6). Similar results
were observed in LNs, when sufficient DNA was recovered from
non-hematopoietic cells for accurate qPCR amplification (data not
shown). While MCMV genomes were also found in the CD45-
positive population on day 7 and 14 post infection, when
productive infection was still ongoing, they were hardly detectable
on day 28, a time point when the virus had already established
latency in both the spleen and the lungs (Fig. 1A). Thus, during the
acute phase of the infection, when CD8 T cells of both the
conventional and inflationary type are primed, MCMV genomes
are found in both hematopoietic and non-hematopoietic cell
compartments. At later time points, when the inflationary memory
CD8 T cell response is induced, MCMV localizes predominantly
in non-hematopoietic cells, strengthening the hypothesis that
latently infected non-hematopoietic cells directly present viral-
derived antigens during latency, leading to memory inflation.
Discussion
MCMV infection induces accumulation and life-long peripheral
maintenance of a population of virus-specific CD8 T cells with an
activated phenotype, a phenomenon referred to as ‘memory
inflation’ [25]. A major population of these inflationary CD8 T
cells in the C57BL/6 background is specific for the MCMV-
derived epitope M38 [28]. The cellular and molecular require-
ments leading to memory inflation are still poorly understood,
mainly due to lack of monoclonal populations of MCMV-specific
CD8 T cells that can be traced in vivo during the course of the
infection. In the present study we describe the generation of two
MHC class I-restricted mouse lines with specificities for the M38-
epitope of MCMV, which differ in their affinity towards the
peptide. Through a series of adoptive transfer experiments we
could demonstrate that i) memory inflation is completely
dependent on antigen presentation by cells of non-hematopoietic
origin, which was recently also reported for mice of non-C57BL/6
background [38], ii) only in lymph nodes inflationary CD8 T cells
respond to continued antigen presentation by proliferation
whereas antigen presentation by non-hematopoietic cells in
peripheral tissues might contribute to their long term effector
phenotype in these tissues during latency, and iii) non-hemato-
poietic cells are the major reservoir of MCMV latent genomes
TEM = 809000/mouse). CFSE dilution was measured 30 days later in the lungs. (H) Representative plots showing the population of transferred cells for
each of the four experimental groups (gated on total CD8 T cell) and their respective CFSE dilutions, and (I) Graphical summary showing percentage
of CFSElow cells among total transferred Maxi CD8 T cells. Data in (I) are pooled from two independent experiments.
doi:10.1371/journal.ppat.1002313.g005
Figure 6. MCMV genome localizes preferentially in non-hematopoietic cells. C57BL/6 mice were infected with MCMV-Dm157 and on day 7,
14 and 28 post infection total cells from the spleen and the lungs were sorted into CD45+ (black circles) and CD45- (white circles) cell populations.
MCMV latent genomes were quantified by qPCR using primers specific for b-actin and the MCMV-encoded M38 gene. One of two independent
experiments is shown.
doi:10.1371/journal.ppat.1002313.g006
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after resolution of acute infection. We propose a model where
memory inflation is induced and maintained by latently infected
non-hematopoietic cells that directly restimulate inflationary CD8
T cells with a TCM phenotype in lymph nodes, inducing secondary
expansion and migration in the periphery.
This model also provides an attractive explanation to why two
patterns of CD8 T cell responses are induced during MCMV
infection, if combined with a recent finding by Hutchinson et al,
who showed that conventional CD8 T cells displayed a higher
dependence on the immunoproteasome subunit LMP7 compared
to inflationary CD8 T cells [39]. The immunoproteaseome is
constitutively expressed by immune cells like DCs and macro-
phages, whereas expression in non-immune cells is only induced
by IFNc [40]. Thus, in non-inflammatory conditions as during
MCMV latency, infected non-hematopoietic cells would only
process proteins through the conventional immunoproteasome.
Inflationary CD8 T cells, in contrast to conventional CD8 T
cells, do not contract upon control of lytic MCMV replication but
rather continuously accumulate even in the absence of overt viral
replication [27,28]. Systematic longitudinal proliferation analyses
allowed the subdivision of the M38-specific CD8 T cell response
into three consecutive phases: a primary expansion characterized
by extensive cell proliferation, immediately followed by a
secondary expansion with reduced but substantial proliferation,
and a maintenance phase, where M38-specific CD8 T cells
stabilized in number and underwent very little proliferation - with
the notable exception of lymph nodes. Primary expansion of M38-
specific CD8 T cells occurred in response to acute infection and
showed high similarities to the conventional M45-specific CD8 T
cell response. In fact, both responses almost completely relied on
antigen presentation by DCs and generated effector cells with
similar effector functions and activation state [28,41]. The two
responses diverged at the peak of the primary expansion, as
conventional CD8 T cells contracted and inflationary CD8 T cells
underwent secondary expansion. Strikingly, secondary expansion
was promoted by robust proliferation which was entirely
dependent on non-hematopoietic cells. Two possible mechanisms
could account for the ability of non-hematopoietic cells to induce
proliferation of inflationary CD8 T cells: one is that infected non-
hematopoietic cells in the periphery perpetuate clonal expansion
that is initiated in the secondary lymphoid organs, as described for
acute LCMV infection [42]. The second is that secondary
expansion is induced in lymph nodes by infected non-hematopoi-
etic cells, re-stimulating inflationary CD8 T cells with a TCM
phenotype, thereby inducing reactivation and migration to the
periphery. Our data support the second hypothesis as the highest
proliferation levels during secondary expansion were not detected
in peripheral organs such as lungs or liver where massive
accumulation of inflationary CD8 T cells was observed, but in
the lymph nodes, where M38-specific CD8 T cells did not inflate
and possessed largely a TCM phenotype. However, since the two
hypotheses are not mutually exclusive, we do not formally rule out
that a certain degree of proliferation might also be induced in
peripheral tissues. Furthermore, although our data clearly show a
strict dependence of antigen recognition on non-hematopoietic
cells for memory inflation to occur, it is possible that memory
inflation could also be stimulated by hematopoietic cells, albeit at
undetectable levels because there might not be enough latently
infected hematopoietic cells to cause inflation on their own.
The proposed scenario where non-hematopoietic cells directly
restimulate TCM CD8 T cells in lymph nodes and induce their
secondary expansion seems reasonable, as it is well-known that
memory CD8 T cells are less stringent in terms of costimulatory
requirements compared to their naı¨ve counterparts and that TCM
CD8 T cells are by far superior in proliferative recall responses as
opposed to TEM CD8 T cells [6,43,44]. Moreover, we recently
showed that memory inflation, in contrast to priming, was largely
independent of CD8a+ and CD103+ DCs [31], which are the
major subsets of cross-presenting DCs described so far, suggesting
that memory inflation is largely driven by direct antigen
presentation. Last but not least, non-hematopoietic cells are the
major reservoir of MCMV latent genomes after resolution of acute
infection in both peripheral and secondary lymphoid organs
[45,46].
While it seems evident that secondary expansion is antigen-
dependent and characterized by extensive proliferation, it is still
unclear what the requirements are for maintenance of the
inflationary pool in the periphery once that true latency is
established. By five months post infection, proliferation of
inflationary CD8 T cells is almost undetectable in the lungs,
although they are maintained at high numbers in this peripheral
tissue. A number of recent reports are consolidating the notion
that so called tissue-resident memory T cells with an effector
memory phenotype can persist in the periphery for long time
periods in the absence of the cognate antigen [7,8,47,48]. Whether
this also applies for MCMV infection remains to be shown.
However, long-term maintenance of virus-specific CD8 T cells are
likely to play an important role during latent infections, where they
would provide a key protective role in active immune surveillance
controlling virus reactivation events, as demonstrated for HSV
infection [8]. The cellular requirements ensuring survival of these
effector cells are still undefined; CD103 expression on CD8 T cells
seems to play a critical role for HSV and other infections [7,8], but
probably not during MCMV as inflationary CD8 T cells do not
express CD103 (data not shown). However, inflationary CD8 T
cells upregulate Bcl-2, also in peripheral tissues and despite
exhibiting a TEM phenotype, suggesting that cytokines or other
stimuli might promote their survival. Yet, it is unlikely that the
inflationary pool is maintained lifelong without being replenished,
as already suggested by Snyder et al [29]. In line with this, we
found a high percentage of proliferating M38-specific CD8 T cells
in the lymph nodes during latency. Moreover, TCM M38-specific
CD8 T cells as opposed to TEM CD8 T cells proliferated in an
antigen-dependent manner when transferred into a latently
infected host. Together, these data indicate that re-stimulation of
TCM memory cells by non-hematopoietic cells in the lymph nodes
might continuously supply the inflationary pool in the periphery
with new and functional effector cells.
Materials and Methods
Ethics statement
This study was carried out in in strict accordance to the
guidelines of the animal experimentation law (SR 455.163; TVV)
of the Swiss Federal Government. The protocol was approved by
Cantonal Veterinary Office of the canton of Zurich, Switzerland
(Permit number 145/2008). All surgery was performed under
isoflurane anesthesia and all efforts were made to minimize
suffering.
Mice, viruses and immunization
C57BL/6N, H-2Kb2/2 and Tg(CD11c-b2m) x Tg(K14-b2m) x
b2m
2/2 (DC-MHCI) mice were bred in the local animal
facility under specific pathogen-free conditions. KM14 mice were
kindly provided by Prof. T. Brocker (Ludwig-Maximilians-
University, Munich). Recombinant MCMV-Dm157 (m157 dele-
tion mutant) was described previously [49] and was grown on
C57BL/6 embryonic fibroblasts (MEFs) and titrated by standard
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plaque-forming assays as described in [50]. Infection was
performed intravenously (i.v.) with 107 plaque forming units
(PFU) of MCMV-Dm157.
Generation of Mini and Maxi transgenic mice
A) Generation of M38316–323-specific CD8 T cell
hybridomas. C57BL/6N mice were infected intravenously
with MCMV-Dm157 and at least 60 days later spleen cells were
isolated and activated for 8 days with 1028 M of M38316–323
peptide (NeoMPS, Strasbourg, France) in presence of 80U/ml of
recombinant IL-2 (BD Biosciences, Basel, Switzerland). Another
restimulation followed, and three days later cells were fused with
BW2 36.1 CD8a cell line (kindly provided by Prof. Marcus
Groettrup, University of Konstanz, Germany) according to the
protocol described in [51]. Specificity of the CD8 T cell
hybridomas was assessed as described in [49]. The hybridoma
with the highest peptide affinity was selected for further
characterization.
b) Identification of TCRVa and TCRVb variable region
genes and generation of TCR transgenic mouse
lines. RNA was isolated form the selected hybridoma using
TRIzol reagent (Invitrogen, Basel, Switzerland) according to the
manufacturer’s instructions, and cDNA was generated using M-
MLV Reverse Transcriptase RNase, H Minus (Promega,
Du¨bendorf, Switzerland). cDNA was amplified with a TCRa-
specific primer set [52] and a TCRb-specific primer set [53].
Sequencing of the PCR products was done by Microsynth (Zu¨rich,
Switzerland) and then aligned to the mouse genome using
Ensemble database (http://www.ensembl.org/Mus_musculus).
The identified Va4Ja13 and Vb10Jb2.1 gene segments were
amplified from the genomic DNA using the following primers: for
Va4Ja13: fwd (59-TGA CCC GGG TTC TAG ATG ACA CTA
AAG ATG G-39), TCRa rev (59-ATA TGC GGC CGC ACA
ATT CAG ACA TGG ACT TAC-39), for Vb10Jb2.1: fwd (59-
TAA CTC GAG GCT TAT TTG CCC TGC CTT GAC CCA
ACT ATG-39), rev (59-TTT CCG CGG CTC CCA CCT GTA
TGG CCT CTG CCT TCT TAC CTA-39). PCR products
containing Va4Ja13 and Vb10Jb2.1 gene segments were digested
with XmaI and NotI respectively with XhoI and SacII and cloned
into previously described TCR expression vectors [35]. The
resulting pTaVa4Ja13 and pTbVb10Jb2.1 were digested with
SalI respectively KpnI to excise the transgenes from prokaryotic
vector DNA. The isolated linearized fragments were co-injected in
equimolar ratios into fertilized C57BL/6N oocytes according to
the standard method [54]. The resulting two TCR transgenic
mouse lines were designated according to the standardized genetic
nomenclature for mice: C57BL/6N-Tg(Tcrb)330Biat (Mini) and
C57BL/6N-Tg(Tcra,Tcrb)329Biat (Maxi) [55].
Generation of bone-marrow chimeras
Chimeric mice were generated by transferring 2–56106 bone
marrow cells derived from C57BL/6N or DC-MHCI mice 6 to
8 hours after lethal irradiation (950 rad) of recipient mice
(C57BL/6N, H-2Kb2/2 or DC-MHCI mice). During the first
two weeks of reconstitution, mice were treated with the
antibacterial Borgal 24% (Intervet, Boxmeer, Netherlands). Bone
marrow chimeric mice were used for experiments 8–10 weeks after
reconstitution.
Antibodies and tetramers
APC-conjugated peptide-MHC class I tetramers were generated
as described in [56]. The following conjugated antibodies were
purchased either from Biolegend (Lucerna Chem AG, Luzern,
Switzerland) or from BD Biosciences (Allschwil, Switzerland):
anti-CD8a [5326.7], anti-CD127 [SB/199], anti-CD62L [MEL-
14], anti-KLRG-1 [2F1], anti-Vb10 [B21.5], anti-CD45.1 [A20],
anti-CD45.2 [104], anti-CD44 [IM7], anti-Ki67 [B56], anti-Bcl-2
[3F11].
Lymphocyte isolation, cell surface and intracellular
staining
Lymphocytes were isolated from spleen, lymph nodes, lungs and
liver as described in [57]. Fresh blood was obtained from the tail
vein. For surface staining, cells were incubated for 20 min at 4uC
or at 37uC when using tetramers before lysis with 1X BD lysis
buffer (BD Biosciences) for 5 min at room temperature. For
intracellular staining of Ki67 and Bcl-2, cells were first
permeabilized by incubation in 1X wash/perm buffer (BD
Biosciences) for 15 minutes at 4uC. Staining was then performed
in 1X wash/perm buffer containing the appropriate antibody
dilutions for 30 min at 4uC. Multiparameter flow cytometric
analysis was performed using a LSRII flow cytometer (BD
Biosciences) and analyzed with FlowJo software (Tree Star, San
Carlos, CA).
Adoptive transfer experiments
CD8 T cells were purified from Mini- or Maxi- derived
splenocytes with anti-CD8a MACS beads (Miltenyi Biotech,
Bergisch Gladbach, Germany) according to the manufacturer’s
instructions and 105 Mini- or 104 Maxi-CD8 T cells were
adoptively transferred into recipient mice one day prior to
infection. For transfer of different CD8 T cell memory subsets,
104 MAXI CD8 T cells were first adoptively transferred into
recipient mice one day prior to infection MCMV-Dm157 as
described above. After at least 60 days post infection, mice were
sacrificed and Maxi CD8 T cells were separated into TCM
(CD62Lhigh IL7Rahigh, cells isolated from pooled lymph nodes and
spleen) and TEM (CD62L
lowIL7Ralow, cells isolated from the
lungs) using a BD FACSAriaTM sorter. Sorted populations of cells
were labeled with 0.5 mM CFSE (Invitrogen, Basel, Switzerland)
for 6 minutes and equal numbers of cells (varying inter-
experimentally between 0.56105 to 16105) were transferred into
latently infected mice or naı¨ve mice. CFSE dilution analysis was
assessed 30 days later in the lymph nodes and in the lungs.
In vitro CD8 T cell proliferation assay
Mini- and Maxi- CD8 T cells were obtained from splenocytes
by MACS positive selection with anti-CD8a microbeads. Cells
were labeled with 0.5 mM CFSE for 6 minutes. DCs were isolated
from the spleen of naı¨ve C57BL/6 mice by MACS positive
selection with anti-CD11c microbeads. 16104 DCs were loaded
with serial dilutions of the M38 peptide epitope and were co-
cultured with 66105 Mini- or 66104 Maxi-CD8 T cells. At day 3
after stimulation, proliferation was measured by CFSE dilution by
flow cytometry.
Quantification of MCMV genomes by qPCR
Spleen and lungs were isolated from mice which have been
infected with MCMV-Dm157 for the indicated time, and single
cell suspensions were obtained as described in [57], except that no
Percoll gradient was performed. Hematopoietic and non-hemato-
poietic cell populations were sorted based on the expression of
CD45. Total genomic DNA was isolated using the Biophenol/
Chloroform/Isoamyl alcohol 25:24:1 reagent (Biosolve Ltd,
Valkenswaard, Netherlands) and isopropanol-based DNA precip-
itation. For qPCR, SYBR green incorporation (Qiagen, Hom-
brechtikon, Switzerland) was measured using a Rotorgene 3000
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machine (Corbett Research, Eight Miles Plains, Australia). The
reaction was carried out using 100 ng of genomic DNA and 5 mM
of primers specific for b-actin (fwd: 59-CCC TGA AGT ACC
CCA TTG AAC-39, rev: 59-CTT TTC ACG GTT GGC CTT
AG-39) or M38 (fwd: 59-AGTCCAGGGTGAGGTCTATG-39,
rev: 59-CCTTCAACTCGGTGCGATTC-39). The relative amount
of MCMV genome was calculated using the delta-delta Ct method.
Results from different runs were normalized using an internal b-actin
standard.
Supporting Information
Figure S1 M38-specifc CD8 T cell populations in
various lymph nodes. Mediastinal, axillary, cervical and
inguinal lymph nodes were pooled from three individual
C57BL/6 mice which had been infected with MCMV-Dm157
for 80 days. Representative plots showing the percentages of M38-
specific CD8 T cells among total lymphocytes are shown for each
lymph node (upper plots), and the lower plots show the expression
of KLRG-1 and IL7Ra on M38-specific CD8 T cells. One of two
independent experiments is shown.
(PDF)
Figure S2 Phenotype of Mini and Maxi CD8 T cells. 105
Mini and 104 Maxi CD8 T cells were adoptively transferred into
C57BL/6 mice one day prior to infection, and blood samples were
collected at the indicated time points after infection with MCMV-
Dm157. Representative plots showing the expression of CD62L
and IL7Ra gated on endogenous (CD45.2) and on transferred
M38-specific CD8 T cells (CD45.1).
(PDF)
Figure S3 Priming of MCMV-specific CD8 T cell
responses in DC-MHCI chimeric mice. WTRWT, DC-
MHCIRDC-MHCI, WTRDC-MHCI, DC-MHCIRWT chi-
meric mice were generated by reconstituting WT and DC-MHCI
irradiated mice with WT and DC-MHCI bone marrow. At least 6
weeks after reconstitution, mice were infected with MCMV-
Dm157 and the M38-and M45-specific CD8 T cells responses
were measured from blood samples on day 7 post infection. One of
two independent experiments is shown.
(PDF)
Figure S4 Bcl-2 expression kinetics in M38- and M45-
specifc CD8 T cells. (A)105 Mini CD8 T cells were transferred
in WTRWT and WTRH-2 Kb2/2 chimeric mice one day prior
to infection with MCMV-Dm157. Blood samples were collected
on days 7, 9, 11, 13, 17, 21, 27, 42 and 60 post infection. Graphs
show the Bcl-2 expression kinetics of M38- (triangles) and M45-
specific (circles) CD8 T cells in WTRWT (left graph) and
WTRH-2 Kb2/2 (right graph) mice. One of two independent
experiments is shown. (B) In a separate experiment, Bcl-2
expression was analyzed for M38- and M45-specific CD8 T cells
in the lungs of mice which had been infected with MCMV-Dm157
for 7, 14, 28 and 150 days. One of two independent experiments is
shown.
(PDF)
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